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Objectfves: To validate the new CardioMed CM 4000 transit time ultrasound apparatus for intraoperative measurement 
of volume blood flow in vivo in man. 
Desfgn: Open, prospective series. 
Materials: Thirteen patients undergoing in situ saphenous vein grafting for chronic critical leg ischaemia nd 12 patients 
subjected to myocardial revascularisation with the internal thoracic artery as coronary bypass. 
Methods: During operations, volume blood flows were measured simultaneously b exsanguination from the cut distal end 
of the in situ saphenous vein graft or the internal thoracic artery and by the transit ime flowmeter equipment. In addition, 
the feasibility to detect arteriovenous fistula during in situ saphenous vein grafting was examined. 
Results: Within the examined blood flow range, the volume blood flow determined by the transit ime method corresponded 
to the directly measured blood flow. For in situ saphenous vein grafts: y = -2.4 + 0.95 • x (r = 0.99; 35 measurements 
in 13 patients), and for internal thoracic artery grafts: y = -9.6 + 1.1 • x (r = 0.99; 21 measurements in 12 patients), 
where y is blood flow determined by transit time, and x is directly measured blood flow by exsanguination (r = correlation 
coefficient) as calculated by the least squares regression method. Fistula detection was easy and swift. 
Conclusions: The transit time apparatus was simple to use during intraoperative settings and gave fast, precise 
measurements ofvolume blood flow. 
Key Words: Blood flow; Critical ischaemia; Myocardial revascularisation; Saphenous vein graft; Transit time; 
Ultrasonography. 
Introduction 
Intraoperative measurement of arterial, venous or 
graft volume blood flow during vascular or cardiac 
surgery is useful for quality control and to reveal 
technical errors. The present study was undertaken to
validate anew transit ime flowmeter (CardioMed CM 
4000, MediStim a/s, Oslo, Norway) for measurements 
of volume blood flow in in situ saphenous vein grafts 
for critical lower limb ischaemia and in internal 
thoracic artery grafts for myocardial revascularisation 
against directly measured volume blood flow by 
exsanguination. I  addition, we examined the ability 
of the transit ime flowmeter to detect arteriovenous 
fistula during in situ saphenous vein grafting. 
Materials and Methods 
Materials 
The examinations of this open, prospective series in a 
university department were performed on 13 patients 
(6 males, median age 72 years, range 49-86) under- 
going in situ saphenous vein grafting for critical 
ischaemia as defined by the European consensus 
document 1 and on 12 patients (8 males, 60 years, range 
44-67) submitted to coronary bypass operations for 
myocardial ischaemia with the internal thoracic artery 
as a graft. The protocol was approved by the local 
ethical committee. 
*Please address all correspondence to: J. Laustsen, Department of 
Cardiothoracic and Vascular Surgery T,Aarhus University Hospital, 
Skejby Sygehus, DK-8200 Aarhus N, Denmark. 
Methods 
Transit time flowmetry. The CardioMed CM4000 transit 
time flow probe for measurement of volume blood 
flow consists of two small piezoelectric crystals, one 
1078-5884/96/050091 + 05 $12.00/0 © 1996 W. B. Saunders Company Ltd. 
92 J. Laustsen et  al. 
upstream and one downstream, mounted in a com- 
mon tip that can be clipped on to the vessel without 
constriction by a movable slider. The front of the probe 
is flat, and a small metallic reflector bracket is 
mounted opposite the crystals. Each crystal can 
produce a wide ultrasound beam covering the entire 
vessel width. Different probes are available for a range 
of vessel diameters (2.0 - 3.5 mm outer diameter: 3.7 
MHz; 3.0 - 6.0 mm o. d.: 2.5 MHz; etc. up to 30 mm 
O.D.). The flowmeter hardware isbuilt into a personal 
computer with > 200 MB storage facilities and a 
modified power supply. The probe is connected to the 
computer that is programmed with software in Micro- 
soft Windows format. The signals (up to four chan- 
nels, i.e., four simultaneous volume blood flow meas- 
urements) are visualised in real-time with relevant 
alphanumeric variables including absolute volume 
blood flow in ml/min and patient data on a video 
screen and, if needed for hard copy documentation, on 
a printer through a parallel port. The degree of 
acoustical coupling is displayed by a colour coded 
square and numerically as a percentage ofthe optimal 
contact. 
The times are measured for an ultrasound pulse 
signal emitted from the upstream crystal to arrive at 
the downstream crystal via the reflector and for a 
signal from the downstream crystal to reach the 
upstream crystal via the reflector. Since ultrasound 
travels faster when it is transmitted in the same 
direction as flow, a small time difference for the two 
signals as expressed in a shift of phase can be 
determined. The angle between probe and vessel is 
not critical since upstream as well as downstream 
crystals are mounted in fixed positions within the 
probe. An increase of the angle between the upstream 
probe and the vessel will always be compensated bya 
corresponding decrease of the angle between the 
downstream probe and the vessel and vice versa. All 
blood flow velocity components are detected by the 
wide ultrasound beam, and transit time determina- 
tions are sampled at all points across the vessel 
diameter, so the measurement of volume blood flow is 
theoretically independent of the blood flow velocity 
profile due to this integration procedure (Fig. 1). 
I. Procedure during in situ saphenous vein grafting. 
Transposition of the saphenous vein to the femoral 
artery was followed by closed valve cutting from the 
cut distal end of the vein. 
(A) Identification of fistula: The transit time flow 
probe was mounted on the proximal part of the graft 
just distal to the anastomosis. By systematic external 
digital compression of the graft from proximal femur 
and distall}~ the localisation of each fistula was easily 
detected, since the transit ime flowmeter immediately 
yielded non-zero flow when digital compression was 
just distal to a fistula. Ligation of all fistulae was 
finally checked by our routine procedure of using a 
Sonicaid Vasoflo 4 (Oxford Sonicaid Ltd, U.K.) ultra- 
sound Doppler equipment with the probe positioned 
just distal to the proximal graft-to-artery anastomosis 
in the groin. 
(B) Volume flow measurements: Direct measurement 
of the blood flowing out from the graft was made by 
letting the blood run freely out into a graduated 
cylinder glass (exsanguination) with simultaneous 
measurement of the volume blood flow by the probe 
of the transit ime flowmeter mounted istally on the 
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Fig. 1. Schematic drawing of the transit time principle for measurement of volume blood flow. The arrows indicate the directions ofthe 
ultrasound beams and volume blood flow, respectively. 
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saphenous vein graft after all fistula had been closed. 
To obtain a wide range of blood flows, the graft was 
compressed slightly in some measurements. Blood 
was collected until a volume of 20-25 ml was 
obtained, and the result was expressed in ml/min. 
Two to three measurements were made in each 
patient. A papaverine test concluded the 
investigations. 
II. Procedure during myocardial revascularisation. The 
internal thoracic artery was mobilised, a short seg- 
ment was skeletonised and soaked with papaverine. 
The probe of the transit time flowmeter was mounted 
on the arter)~ and during the transit ime volume flow 
recordings, the blood flowing from the cut end of the 
artery was collected in a graduated cylinder glass. The 
artery was compressed igitally in some cases to 
obtain a wide range of flows. Blood was collected until 
a volume of 20-25 ml was obtained, and the result was 
expressed in ml/min. One to three measurements 
were made in each patient. 
III. General procedures. Before each measurement with 
the transit ime flowmeter, the zero point stability was 
tested with the probes mounted on the most distal 
part of the skeletonised saphenous vein or internal 
thoracic artery grafts, respectively, that were clamped 
at the outlet. In all cases, optimal acoustical contact 
between probe and vessel was ensured by using sterile 
ultrasound gel (Ultra/Phonic Conductivity Gel, Phar- 
maceutical Innovations Inc., U.S.A.). 
IV. Statistics. The results of the measurements with the 
transit time equipment and with exsanguination were 
analysed using the computer programmes Excel 5.0 
(Microsoft) and Statistica 3.0b (Statsoft, Inc.) for least 
squares linear regression analysis. 
Results 
The system was zero point stable in all cases. A total of 
35 simultaneous measurements by transit time flow- 
metry and exsanguination were made during 13 in situ 
procedures, and 21 measurements were made in 12 
patients during myocardial revascularisation with the 
internal thoracic artery. The directly measured mean 
volume blood flow by exsanguination was 117 ml/ 
min (range 26-394) for the in situ vein and 64 ml/min 
(range 20 - 207) for the internal thoracic artery. An 
experimental tracing of the transit time flow curve is 
reproduced as Fig. 2. The results are presented in Figs. 
3 and 4, where the volume blood flow values 
determined by the transit time flowmeter (y-axis) are 
plotted against the directly measured volume blood 
flows by the exsanguination procedure (x-axis) in a 
linear diagram. The data were analysed by the least 
squares linear regression method giving y = -2.4 + 
0.95.x and a correlation coefficient, r of 0.99 for in situ 
vein grafts (Fig. 3), and y = -9.6 + 1.1.x and r = 0.99 
for internal thoracic artery grafts (Fig. 4). Figs. 5 and 6 
present he differences in volume blood flow between 
the transit time and the exsanguination procedures 
according to the principles described by Bland and 
Altman. 2 
Discussion 
The first transit time flowmeter was described by 
Franklin et al. 3 and Plass, 4 but the theoretical basis for 
volume flow measurements with the transit time 
principle was developed by Drost. 5 Transit time 
flowmetry is theoretically independent of internal or 
external vessel diameters, vessel shape and blood flow 
profile. It is, in contrast to ultrasound Doppler 
techniques, insensitive to the alignment between 
probe and vessel. The probe does not have to be in 
direct contact with the vessel wall, but acoustical f uid 
(gel, blood) must be present between blood vessel and 
probe to ensure good acoustical coupling. Homoge- 
neous distribution of blood flow within the cross 
sectional area of the vessel is not necessary. The 
volume flow measurement is independent on haema- 
tocrit fraction, on the value of the heart rate and on the 
thickness of the vessel wall. There is no zero drift of 
the recorded signal, and calibration is unnecessary. 
Instantaneous and mean volume blood flows are 
expressed in ml/min (see Fig. 2). The recordings are 
stable and, with the present equipment, data storage 
and analysis are conveniently done in an intuitive 
interface. 
Due to the air contents of polytetrafluoroethylene 
(PTFE) or coated Dacron grafts, transit time ultra- 
sound cannot be used for measurements of flow in 
these grafts since air attenuates ultrasound. The flat 
probe design reduces the risk of trapping air between 
probe and vessel wall. In practice, the diameter of the 
probe should correspond well to the outer diameter of 
the vessel, in order to obtain optimal acoustical 
contact. Spasms were prone to occur in segments of 
the mobilised internal thoracic artery during manip- 
ulation and dissection, but these disappeared after 
pressurising. Minor changes in the angle between 
probe and vessel did not influence measurements, but 
errors occurred after twisting of the probe in relation 
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to the wall. For this reason the probe should be 
aligned to the longitudinal axis of the wall. 
Transit time technology has previously been shown 
to correlate well to oesophageal ultrasound Doppler 
and to the thermodilution techniques for measure- 
ment of cardiac output in pigs, 6 to thermodilution 
methods for pulmonary arterial and portal venous 
blood flows in pigs, 7 to carotid arteries in sheep 
(exsanguination) and in vitro, 8 and to electromagnetic 
flowmeters in ascending aortas in dogs and abdomi- 
nal aortas in cats. 9 In rats, 1 and 2 mm probes were 
used for measurements of mesenteric artery and aorta 
blood flows 1° where the 2 mm probe slightly overesti- 
mated flow in the medium range. 
An in vitro study showed a slight overestimation of
blood flow with transit time technique but excellent 
correlation between transit time and directly meas- 
ured blood flow. Additional in vivo measurements on
nine saphenous vein grafts for aortocoronary bypass 
with transit time and ultrasound Doppler showed 
excellent agreement with a correlation coefficient of 
0.990 at a transit time blood flow = 1.3 + 1.00 • 
Doppler blood flow. 11 In the series of 63 patients 
undergoing myocardial revascularisation, blood flows 
in internal thoracic artery grafts and saphenous vein 
grafts were measured after the bypass procedures. In 
two cases, flow impedance due to twist of the pedicle 
at the distal anastomosis was detected by the transit 
time equipment. The features of the second generation 
transit time flowmeter as used in the present study 
differ from those of the first generation flowmetres by 
having real time on line visualisation of flow curves 
on a colour monitor screen and build in facilities for 
storage and post processing. The present stud~ which 
is the first reported series with a second generation 
transit time flowmeter, showed that the equipment 
was simple and convenient to use in clinical intra- 
operative settings. 
Date: 
Patient: 
Patient ID: 
11:44 - 16. Mar - 1995 Comments: 
8O 
6O 
4o 
E 20 
-20 
Q1 ] 
. . . . . . . . .  !V_  ~_  l . . . .  J . . . .  i. 
- -V -  -k /~ x / "  - V - ' -  . . . . .  
Probe: 3 mm Filter: 20 Hz dist [ ]  0 ml/min 
Probe: 4 mm Filter: 20 Hz prox J 
165 ml/min 
Fig. 2. An example of the recorded transit time volume flow curves for an in situ saphenous vein graft after four fistula had been clamped. 
The upper panel shows the signal obtained with a 3 mm transit ime flow probe positioned close to the distal end of the vein that was 
clamped just distal to the probe. A volume blood flow of 0 ml/min was recorded. The lower panel presents he simultaneously recorded 
tracing obtained by placing a 4 mm transit ime probe on the graft just distal to the proximal anastomosis between the common femoral 
artery and the in situ saphenous vein graft. The volume flow at this position was 165 ml/min which indicated that one or more fistula 
remained to be clamped. The shaded square areas in the lower right hand corner of each panel display a colour code for the acoustical 
coupling between probe and graft and a numerical value designating the percentage of optimal contact. 
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Fig. 3. Linear plot of the volume blood flow as measured by the 
transit time ultrasound method (y) against volume blood flow as 
determined by exsanguination (x) during in situ saphenous vein 
grafting for critical eg ischaemia (35 measurements in 13 patients). 
SEE is standard error of the estimate, and r is correlation coefficient. 
The straight line was calculated by least squares regression analysis. 
The interrupted line represents y = x. 
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Fig. 4. Linear plot of the volume blood flow as measured by the 
transit ime method (y) against volume blood flow as determined by 
exsanguination (x) during myocardial revascularisation with the 
internal thoracic artery as coronary bypass (21 measurements in 12 
patients). SEE is standard error of the estimate, and r is correlation 
coefficient. The straight line was calculated by least squares 
regression analysis. The interrupted line represents y = x. 
Finding of fistula during saphenous vein in situ 
grafting was simple, and the method was in practice 
superior to our conventional technique for ultrasound 
Doppler fistula localization because of zero line 
stability and the ability to measure very low blood 
flow values. In addition, volume blood flow through 
individual fistula was easily determined. The possibil- 
ity to inspect real time blood flow wave forms instead 
of ultrasound Doppler velocities is a major advantage 
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Fig. 5. The difference in volume blood flow between the transit ime 
ultrasound and the exsanguination procedures for the in situ 
saphenous vein graft experiments (y-axis) is plotted against the 
mean volume blood flow (ml/min) (x-axis) in accordance with the 
2 principles described by Bland and Altman. The solid line symbol- 
ises the mean value of all measurements, and the dashed line 
denotes mean plus two times the standard eviation (SD) at the top 
and mean minus 2 times SD at the bottom. 
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Fig. 6. The difference in volume blood flow between the transit ime 
ultrasound and the exsanguination procedures for the internal 
thoracic artery graft procedures (y-axis) is plotted against he mean 
volume blood flow (ml/min) (x-axis) in the same way as in Fig. 5. 
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of the transit ime system, especially during papaver- 
ine tests after vascular reconstructions° The time 
needed to do the volume flow measurements was 
short, the practical procedures were easy to learn and 
execute, and the operation of the system was simple 
due to the graphical operation interface of the com- 
puter. The probes can be sterilised and reused. 
The agreement between the transit time volume 
blood flow values and the directly measured blood 
flows has made the present technology our method of 
choice for routine clinical uses for measurement of 
volume blood flow in venous grafts and arteries. 
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